Conference
Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel
Abstract
Abstract
Authors
Schuster SJ; Bishop MR; Tam C; Borchmann P; Jaeger U; Waller EK; Holte H; McGuirk JP; Jaglowski S; Tobinai K
Volume
132
Publisher
American Society of Hematology
Publication Date
November 29, 2018
DOI
10.1182/blood-2018-99-115252
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971